These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8299739

  • 1. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S, Mantel C, Broxmeyer HE.
    Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
    [Abstract] [Full Text] [Related]

  • 2. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
    Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE.
    J Immunol; 1992 Aug 01; 149(3):1004-9. PubMed ID: 1634758
    [Abstract] [Full Text] [Related]

  • 3. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A.
    J Immunol; 1991 Oct 15; 147(8):2586-94. PubMed ID: 1918979
    [Abstract] [Full Text] [Related]

  • 4. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [Abstract] [Full Text] [Related]

  • 5. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.
    Mantel C, Kim YJ, Cooper S, Kwon B, Broxmeyer HE.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2232-6. PubMed ID: 8460127
    [Abstract] [Full Text] [Related]

  • 6. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Mar 15; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 7. Induction of murine peritoneal macrophage colony-forming cells by peritoneal administration of macrophage inflammatory protein-1 alpha.
    Chen B, Chou TH, Sensenbrenner L.
    Exp Hematol; 1993 Nov 15; 21(12):1591-6. PubMed ID: 8405240
    [Abstract] [Full Text] [Related]

  • 8. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C.
    Ann Hematol; 1995 Nov 15; 71(5):235-46. PubMed ID: 7492626
    [Abstract] [Full Text] [Related]

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 10. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    Mantel C, Aronica S, Luo Z, Marshall MS, Kim YJ, Cooper S, Hague N, Broxmeyer HE.
    J Immunol; 1995 Mar 01; 154(5):2342-50. PubMed ID: 7532666
    [Abstract] [Full Text] [Related]

  • 11. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer.
    Broxmeyer HE, Orazi A, Hague NL, Sledge GW, Rasmussen H, Gordon MS.
    Blood Cells Mol Dis; 1998 Mar 01; 24(1):14-30. PubMed ID: 9516378
    [Abstract] [Full Text] [Related]

  • 12. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
    Youn BS, Jang IK, Broxmeyer HE, Cooper S, Jenkins NA, Gilbert DJ, Copeland NG, Elick TA, Fraser MJ, Kwon BS.
    J Immunol; 1995 Sep 01; 155(5):2661-7. PubMed ID: 7650394
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
    Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z.
    Leukemia; 1994 May 01; 8(5):798-805. PubMed ID: 8182937
    [Abstract] [Full Text] [Related]

  • 14. Effects in vivo of recombinant human inhibin on myelopoiesis in mice.
    Hangoc G, Carow CE, Schwall R, Mason AJ, Broxmeyer HE.
    Exp Hematol; 1992 Nov 01; 20(10):1243-6. PubMed ID: 1426104
    [Abstract] [Full Text] [Related]

  • 15. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.
    Stem Cells; 1993 Oct 01; 11 Suppl 3():122-8. PubMed ID: 8298472
    [Abstract] [Full Text] [Related]

  • 16. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
    Broxmeyer HE, Pelus LM, Kim CH, Hangoc G, Cooper S, Hromas R.
    Exp Hematol; 2006 Aug 01; 34(8):1069-77. PubMed ID: 16863913
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML, Vaudrain T, Correira H, Martin T, Reese D.
    Exp Hematol; 1998 Dec 01; 26(13):1247-54. PubMed ID: 9845381
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
    Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB.
    Nature; 1990 Mar 29; 344(6265):442-4. PubMed ID: 2320111
    [Abstract] [Full Text] [Related]

  • 19. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
    Pelus LM, King AG, Broxmeyer HE, DeMarsh PL, Petteway SR, Bhatnagar PK.
    Exp Hematol; 1994 Mar 29; 22(3):239-47. PubMed ID: 8112423
    [Abstract] [Full Text] [Related]

  • 20. The ex vivo expansion of feline marrow cells leads to increased numbers of BFU-E and CFU-GM but a loss of reconstituting ability.
    Abkowitz JL, Taboada MR, Sabo KM, Shelton GH.
    Stem Cells; 1998 Mar 29; 16(4):288-93. PubMed ID: 9708451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.